Book Appointment with Dr Deepanjali Adulkar in Mumbai
Dr Deepanjali Adulkar
Radiation Oncologist
11 Years Exp. Mumbai
Breast Cancer
HCG ICS Khubchandani, Mumbai
11 years of experience
MBBS, DNB - Radiotherapy,Fellowship in Advanced Radiation Oncology
About Dr Deepanjali Adulkar:
Dr Deepanjali Adulkar is a Consultant, Radiation Oncology at HCG Mumbai. She is well versed with all aspects of Oncology and multidisciplinary management of all types of cancers. Dr Deepanjali's primary expertise is IMRT/ IGRT, SRS/SRT/SBRT, Respiratory gating, PET based planning, Adaptive radiotherapy. She has done significant work in Geriatric Oncology, treatment of left sided breast cancers with DIBH technique and currently is conducting a research on Gastrointestinal malignancies. She has published numerous research papers/abstracts in national and international journals and has been the recipient of Best Paper at the Young Radiation oncologist Conference, 2013. Dr Deepanjali believes in complete comprehensive cancer care & utilization of better techniques for improved survival & quality of life for patients.
Education:
MBBS - King Edward Memorial Hospital and Seth Gordhandas Sunderdas Medical College, 2009 DNB - Radiotherapy - National Board Of Examination, 2014 Fellowship in Advanced Radiation Oncology - Tata Memorial Hospital, Mumbai, 2017
Experience:
Resident in Radiation Oncology, Yashoda Hospitals, Hyderabad April, 2012 - April, 2015 Consultant Radiation Oncologist, MPCT hospital- A Surana Associate, Mumbai September, 2017 - April, 2018 Consultant Oncologist, Navnath Heathcare, Mumbai April, 2018 - October, 2018 Consultant Radiation Oncologist, Tata Memorial Hospital, Mumbai October, 2018 - November, 2019 Consultant Radiation Oncologist, HCG Cancer Centre, Mumbai November, 2019 - Present
Memberships:
Association of Radiation Oncologists of India (AROI) Association of Gynecologic Oncologists of India (AGOI)
Areas of interest:
Breast Cancer, Gastrointestinal (GI) Cancer, Primary Central Nervous System (CNS) Lymphoma, Genitourinary Cancer, Gynecological Cancer, Head And Neck Cancer.
Research publications:
Chilukuri, Srinivas & ChandaSekhar, N. & Umamahesh, M. & Rajani, Salman & Adulkar, Deepanjali & Keskar, S.. (2013). Is it Time to Revise Imaging Guidelines for Response Assessment After Temoradiation and Surgery for GBM? Sensitivity, Specificity, and Predictive Value of MR Spectroscopy and Perfusion for the Detection of Tumor Progression After Temoradiation. International Journal of Radiation Oncology*Biology*Physics. 87. S259. https://doi.org/10.1016/j.ijrobp.2013.06.673 Chilukuri, Srinivas & Mohammad, N. & Adulkar, Deepanjali & Subramaniam, V.S. & Gandhi, A. & Shanmugam, Thirumalai & Murugesan, Kathirvel & Ghadyalpatil, N.S. & Sreekanth, K.. (2014). Two Prescription Dose Levels as Safe as 3-4 Prescription Dose Levels in IMRT for the Treatment of Neck Nodal Regions in Head and Neck Cancers. International Journal of Radiation Oncology*Biology*Physics. 90. S550. https://doi.org/10.1016/j.ijrobp.2014.05.1669 Chilukuri, Srinivas & Adulkar, Deepanjali & Subramaniam, S. & Mohammed, Nadiah & Gandhi, A. & Murugesan, Kathirvel & Shanmugam, Thirumalai & Kumar, K. & Yadala, N.. (2016). PO-0881: Patient selection for DIBH technique for left sided breast cancers: Impact of chest wall shape. Radiotherapy and Oncology. 119. S422. https://doi.org/10.1016/S0167-8140(16)32131-4 Agarwal, Jai & Adulkar, Deepanjali & Swain, Monali & Chakraborty, Santam & Gupta, Tejpal & Budrukkar, Ashwini & Ghosh Laskar, Sarbani & Murthy, Vedang. (2018). Influence of comorbidity on therapeutic decision making and impact on outcomes in patients with head and neck squamous cell cancers: Results from a prospective cohort study. Head & Neck. 41. https://doi.org/10.1002/hed.25408 Adulkar, Deepanjali & Saklani, Avanish & Desouza, A. & Ostwal, Vikas & Ramaswamy, Anant & Baheti, A. & Katdare, A.. (2019). OC-082: Does Lateral Pelvic Lymph-node dissection improve outcomes in locally advanced Ca rectum?. Radiotherapy and Oncology. 141. S35-S36. https://doi.org/10.1016/S0167-8140(20)30451-5
Specialisation
Breast Cancer, Gastrointestinal (GI) Cancer, Primary Central Nervous System (CNS) Lymphoma, Genitourinary Cancer, Gynecological Cancer, Head And Neck Cancer.
